Wang, Xiaoyang
Tian, Jianbo
Zhao, Qianyu
Yang, Nan
Ying, Pingting
Peng, Xiating
Zou, Danyi
Zhu, Ying
Zhong, Rong
Gao, Ying
Chang, Jiang
Miao, Xiaoping http://orcid.org/0000-0002-6818-9722
Funding for this research was provided by:
National Natural Science Foundation of China (81872696)
National Program for Support of Top-notch Young Professionals
the Young Elite Scientist Sponsorship Program by CAST (2018QNRC001)
the Natural Science Foundation of Hubei Province for Innovative Research Groups (2019CFA009)
National Key Research and Development Plan Program (2016YFC1302702, 2016YFC1302703)
Program for HUST Academic Frontier Youth Team
Article History
Received: 10 January 2020
Accepted: 6 April 2020
First Online: 9 May 2020
Compliance with ethical standards
:
: The authors declare no conflicts of interest.
: All procedures involving human participants were in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Data on plasma palmitate levels were obtained from Peiqin Li et al.’s study (Li et al. CitationRef removed) and the study design was approved by the Institutional Review Board of the Chinese Center for Disease Control and Prevention. RNA-seq data of <i>FASN</i> were obtained from our previous study (Chang et al. CitationRef removed) and the study was approved by the Institutional Review Board of the Chinese Academy of Medical Sciences, Cancer Institute and Zhejiang Cancer Hospital. All participants gave written informed consent.